| Stockholders' Equity and Accumulated Other Comprehensive Income (Loss) |
NOTE 14. SHAREHOLDERS' EQUITY AND ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) PREFERRED STOCK The following table presents a summary of the non-cumulative perpetual preferred stock: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | 2024 | | 2023 | | Issuance Date | | Earliest Redemption Date | | Dividend Rate (1) | | Liquidation Amount | | Liquidation preference per Share | | Liquidation preference per Depositary Share | | Ownership Interest per Depositary Share | | Shares Issued and Outstanding | | Carrying Amount | | Carrying Amount | | (Dollars in millions, except for share and per share amounts) | Series B(2) | 4/29/2014 | | 9/15/2024 | | 6.375 | % | | | $ | — | | | $ | 1,000 | | | $ | 25 | | | 1/40th | | — | | | $ | — | | | $ | 433 | | | Series C | 4/30/2019 | | 5/15/2029 | | 5.700 | % | (3) | | 500 | | | 1,000 | | | 25 | | | 1/40th | | 500,000 | | 490 | | | 490 | | | Series D | 6/5/2020 | | 9/15/2025 | | 5.750 | % | (4) | | 350 | | | 100,000 | | | 1,000 | | | 1/100th | | 3,500 | | 346 | | | 346 | | | Series E | 5/4/2021 | | 6/15/2026 | | 4.450 | % | | | 400 | | | 1,000 | | | 25 | | | 1/40th | | 400,000 | | 390 | | | 390 | | | Series F | 7/29/2024 | | 9/15/2029 | | 6.950 | % | (5) | | 500 | | | 1,000 | | | 25 | | | 1/40th | | 500,000 | | | 489 | | | — | | | | | | | | | | $ | 1,750 | | | | | | | | | 1,403,500 | | | $ | 1,715 | | | $ | 1,659 | |
_________ (1)Dividends on all series of preferred stock, if declared, accrue and are payable quarterly in arrears. (2)The shares were fully redeemed on September 16, 2024. (3)Dividends, if declared, will be paid quarterly at an annual rate equal to (i) for each period beginning prior to August 15, 2029, 5.700%, and (ii) for each period beginning on or after August 15, 2029, three-month CME Term SOFR plus 3.410% which includes a 0.262% spread adjustment for the transition to SOFR in accordance with ISDA protocols. (4)Dividends, if declared, will be paid quarterly at an annual rate equal to (i) for each period beginning prior to September 15, 2025, 5.750%, and (ii) for each period beginning on or after September 15, 2025, the five-year Treasury rate as of the most recent reset dividend determination date plus 5.426%. (5)Dividends, if declared, will be paid quarterly at an annual rate equal to (i) for each period beginning prior to September 15, 2024, 6.950% and (ii) for each period beginning on or after September 15, 2029, the five-year Treasury rate as of the most recent reset dividend determination date plus 2.771%. All series of preferred stock have no stated maturity and redemption is solely at Regions' option, subject to regulatory approval, in whole, or in part, after the earliest redemption date or in whole, but not in part, at any time following a regulatory capital treatment event for the Series C, Series D, Series E, and Series F preferred stock. Regions completed the issuance of Series F preferred stock during the third quarter of 2024 as shown in the table above. The Company incurred $11 million of issuance costs associated with the transaction with an initial partial dividend occurring in the third quarter. The Series B preferred stock was redeemed in the third quarter of 2024. Upon redemption, additional paid-in-capital was reduced by $52 million related to Series B preferred dividends that were recorded as a reduction of preferred stock, including related surplus, and net income available to common shareholders was reduced by $15 million related to issuance costs. The Board of Directors declared cash dividends of $91 million and $98 million on Series B, Series C, Series D, and Series E of preferred stock during 2024 and 2023, respectively. The board declared $13 million in cash dividends on Series F preferred stock during 2024; the initial quarterly cash dividend for Series F preferred stock was declared in the third quarter of 2024. In total, the Board of Directors declared $104 million and $98 million in cash dividends on preferred stock in 2024 and 2023, respectively. In the event Series C, Series D, Series E, or Series F preferred shares are redeemed in full at their respective liquidation amounts, $10 million, $4 million, $10 million, or $11 million in excess of the redemption amount over the carrying amount will be recognized, respectively. These excess amounts represent issuance costs that were recorded as reductions to preferred stock, including related surplus, and will be recorded as reductions to net income available to common shareholders. COMMON STOCK The Company's results of the 2024 stress test from the Federal Reserve reflect that the Company exceeded all minimum capital levels. The Company's SCB will remain floored at 2.5 percent from the fourth quarter of 2024 through the third quarter of 2025. On April 20, 2022, the Board authorized the repurchase of up to $2.5 billion of the Company's common stock, permitting purchases from the second quarter of 2022 through the fourth quarter of 2024. As of December 31, 2024, Regions had repurchased approximately 34 million shares of common stock at a total cost of $614 million under this plan. All of these shares were immediately retired upon repurchase and therefore were not included in treasury stock. On December 10, 2024, the Board authorized an extension of the common stock repurchase program through the fourth quarter of 2025. Regions declared $0.98 per share in cash dividends for 2024, $0.88 per common share for 2023, and $0.74 for 2022. | | | | | | | | | | | | | | | | | | | | 2024 | | | Pre-tax AOCI Activity | | Tax Effect and Other (1) | | Net AOCI Activity | | | (In millions) | | Total accumulated other comprehensive income (loss), beginning of period | $ | (3,773) | | | $ | 961 | | | $ | (2,812) | | | | | | | | | Unrealized losses on securities transferred to held to maturity: | | | | | | | Beginning balance | $ | (9) | | | $ | 1 | | | $ | (8) | | | Unrealized gains (losses) on securities transferred from available for sale during the period | (754) | | | 192 | | | (562) | | Reclassification adjustments for amortization on unrealized losses on securities transferred to held for maturity (2) | 19 | | | (5) | | | 14 | | | Change in AOCI from securities held to maturity activity in the period | (735) | | | 187 | | | (548) | | | Ending balance | $ | (744) | | | $ | 188 | | | $ | (556) | | | Unrealized gains (losses) on securities available for sale: | | | | | | | Beginning balance | $ | (2,759) | | | $ | 703 | | | $ | (2,056) | | | Unrealized (gains) losses on securities transferred to held to maturity during the period | 754 | | | (192) | | | 562 | | | Unrealized gains (losses) arising during the period | (161) | | | 31 | | | (130) | | Reclassification adjustments for securities (gains) losses realized in net income (3) | 208 | | | (52) | | | 156 | | | Change in AOCI from securities available for sale activity in the period | 801 | | | (213) | | | 588 | | | Ending balance | $ | (1,958) | | | $ | 490 | | | $ | (1,468) | | | Unrealized gains (losses) on derivative instruments designated as cash flow hedges: | | | | | | | Beginning balance | $ | (399) | | | $ | 102 | | | $ | (297) | | | Unrealized gains (losses) on derivatives arising during the period | (683) | | | 172 | | | (511) | | Reclassification adjustments for (gains) losses realized in net income (2) | 420 | | | (106) | | | 314 | | | Change in AOCI from derivative activity in the period | (263) | | | 66 | | | (197) | | | Ending balance | $ | (662) | | | $ | 168 | | | $ | (494) | | | Defined benefit pension plans and other post employment benefit plans: | | | | | | | Beginning balance | $ | (606) | | | $ | 155 | | | $ | (451) | | | Net actuarial gains (losses) arising during the period | 27 | | | (9) | | | 18 | | Reclassification adjustments for amortization of actuarial (gains) losses and settlements realized in net income (4) | 31 | | | (8) | | | 23 | | | Change in AOCI from defined benefit pension plans and other post employment benefits activity in the period | 58 | | | (17) | | | 41 | | | Ending balance | $ | (548) | | | $ | 138 | | | $ | (410) | | | | | | | | | Total other comprehensive income (loss) | (139) | | | 23 | | | (116) | | | Total accumulated other comprehensive income (loss), end of period | $ | (3,912) | | | $ | 984 | | | $ | (2,928) | |
| | | | | | | | | | | | | | | | | | | | | | | 2023 | | Pre-tax AOCI Activity | | Tax Effect (1) | | Net AOCI Activity | | | | | | (In millions) | | | | | | Total accumulated other comprehensive income (loss), beginning of period | $ | (4,481) | | | $ | 1,138 | | | $ | (3,343) | | | | | | | | | | | | | | | | | Unrealized losses on securities transferred to held to maturity: | | | | | | | | | | | Beginning balance | $ | (11) | | | $ | 2 | | | $ | (9) | | | | | | Reclassification adjustments for amortization on unrealized losses (2) | 2 | | | (1) | | | 1 | | | | | | | Ending balance | $ | (9) | | | $ | 1 | | | $ | (8) | | | | | | | Unrealized gains (losses) on securities available for sale: | | | | | | | | | | | Beginning balance | $ | (3,433) | | | $ | 872 | | | $ | (2,561) | | | | | | | Unrealized gains (losses) arising during the period | 669 | | | (168) | | | 501 | | | | | | Reclassification adjustments for securities (gains) losses realized in net income (3) | 5 | | | (1) | | | 4 | | | | | | | Change in AOCI from securities available for sale activity in the period | 674 | | | (169) | | | 505 | | | | | | | Ending balance | $ | (2,759) | | | $ | 703 | | | $ | (2,056) | | | | | | | Unrealized gains (losses) on derivative instruments designated as cash flow hedges: | | | | | | | | | | | Beginning balance | $ | (468) | | | $ | 119 | | | $ | (349) | | | | | | | Unrealized gains (losses) on derivatives arising during the period | (167) | | | 43 | | | (124) | | | | | | Reclassification adjustments for (gains) losses realized in net income (2) | 236 | | | (60) | | | 176 | | | | | | | Change in AOCI from derivative activity in the period | 69 | | | (17) | | | 52 | | | | | | | Ending balance | $ | (399) | | | $ | 102 | | | $ | (297) | | | | | | | Defined benefit pension plans and other post employment benefit plans: | | | | | | | | | | | Beginning balance | $ | (569) | | | $ | 145 | | | $ | (424) | | | | | | | Net actuarial gains (losses) arising during the period | (82) | | | 21 | | | (61) | | | | | | Reclassification adjustments for amortization of actuarial (gains) losses and settlements realized in net income (4) | 45 | | | (11) | | | 34 | | | | | | | Change in AOCI from defined benefit pension plans and other post employment benefits activity in the period | (37) | | | 10 | | | (27) | | | | | | | Ending balance | $ | (606) | | | $ | 155 | | | $ | (451) | | | | | | | | | | | | | | | | | Total other comprehensive income (loss) | 708 | | | (177) | | | 531 | | | | | | | Total accumulated other comprehensive income (loss), end of period | $ | (3,773) | | | $ | 961 | | | $ | (2,812) | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | 2022 | | Pre-tax AOCI Activity | | Tax Effect (1) | | Net AOCI Activity | | | | | | (In millions) | | | | | | Total accumulated other comprehensive income (loss), beginning of period | $ | 387 | | | $ | (98) | | | $ | 289 | | | | | | | | | | | | | | | | | Unrealized losses on securities transferred to held to maturity: | | | | | | | | | | | Beginning balance | $ | (14) | | | $ | 3 | | | $ | (11) | | | | | | Reclassification adjustments for amortization on unrealized (gains) losses (2) | 3 | | | (1) | | | 2 | | | | | | | Ending balance | $ | (11) | | | $ | 2 | | | $ | (9) | | | | | | | Unrealized gains (losses) on securities available for sale: | | | | | | | | | | | Beginning balance | $ | 218 | | | $ | (55) | | | $ | 163 | | | | | | | Unrealized gains (losses) arising during the period | (3,652) | | | 927 | | | (2,725) | | | | | | Reclassification adjustments for securities losses realized in net income (3) | 1 | | | — | | | 1 | | | | | | | Change in AOCI from securities available for sale activity in the period | (3,651) | | | 927 | | | (2,724) | | | | | | | Ending balance | $ | (3,433) | | | $ | 872 | | | $ | (2,561) | | | | | | | Unrealized gains (losses) on derivative instruments designated as cash flow hedges: | | | | | | | | | | | Beginning balance | $ | 830 | | | $ | (209) | | | $ | 621 | | | | | | | Unrealized gains (losses) on derivatives arising during the period | (1,158) | | | 292 | | | (866) | | | | | | Reclassification adjustments for (gains) losses realized in net income (2) | (140) | | | 36 | | | (104) | | | | | | | Change in AOCI from derivative activity in the period | (1,298) | | | 328 | | | (970) | | | | | | | Ending balance | $ | (468) | | | $ | 119 | | | $ | (349) | | | | | | | Defined benefit pension plans and other post employment benefit plans: | | | | | | | | | | | Beginning balance | $ | (647) | | | $ | 163 | | | $ | (484) | | | | | | | Net actuarial gains (losses) arising during the period | 40 | | | (7) | | | 33 | | | | | | Reclassification adjustments for amortization of actuarial (gains) losses and settlements realized in net income (4) | 38 | | | (11) | | | 27 | | | | | | | Change in AOCI from defined benefit pension plans and other post employment benefits activity in the period | 78 | | | (18) | | | 60 | | | | | | | Ending balance | $ | (569) | | | $ | 145 | | | $ | (424) | | | | | | | | | | | | | | | | | Total other comprehensive income (loss) | (4,868) | | | 1,236 | | | (3,632) | | | | | | | Total accumulated other comprehensive income (loss), end of period | $ | (4,481) | | | $ | 1,138 | | | $ | (3,343) | | | | | |
____ (1)The impact of all AOCI activity is shown net of tax, the tax effect is calculated using a nominal rate of approximately 25 percent. (2)Reclassification amount is recognized in net interest income in the consolidated statements of income. (3)Reclassification amount is recognized in securities gains (losses), net in the consolidated statements of income. (4)Reclassification amount is recognized in other non-interest expense in the consolidated statements of income. Additionally, these accumulated other comprehensive income (loss) components are included in the computation of net periodic pension cost (see Note 17 for additional details).
|